Patents by Inventor John Strang

John Strang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE
    Publication number: 20240082149
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HCl dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Application
    Filed: September 19, 2023
    Publication date: March 14, 2024
    Inventors: John Strang, Alexander Oksche, Stephen Harris, Kevin Smith, Lucie Helene Jeanne Mottier
  • Intranasal pharmaceutical dosage forms comprising naloxone
    Patent number: 11806428
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HCl dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: November 7, 2023
    Assignee: HARM REDUCTION THERAPEUTICS, INC.
    Inventors: John Strang, Alexander Oksche, Stephen Harris, Kevin Smith, Lucie Helene Jeanne Mottier
  • INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE
    Publication number: 20210338574
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HCl dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Application
    Filed: April 23, 2021
    Publication date: November 4, 2021
    Inventors: John Strang, Alexander Oksche, Stephen Harris, Kevin Smith, Lucie Helene Jeanne Mottier
  • Intranasal pharmaceutical dosage forms comprising naloxone
    Patent number: 11020343
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HC dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: June 1, 2021
    Assignee: Harm Reduction Therapeutics, Inc.
    Inventors: John Strang, Alexander Oksche, Stephen Harris, Kevin Smith, Lucie Helene Jeanne Mottier
  • INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE
    Publication number: 20190374464
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HC dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Application
    Filed: August 23, 2019
    Publication date: December 12, 2019
    Inventors: John STRANG, Alexander OKSCHE, Stephen HARRIS, Kevin SMITH, Lucie Helene Jeanne MOTTIER
  • INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE
    Publication number: 20170304192
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HCl dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Application
    Filed: May 9, 2017
    Publication date: October 26, 2017
    Inventors: John STRANG, Alexander OKSCHE, Stephen HARRIS, Kevin SMITH, Lucie Helene Jeanne MOTTIER
  • Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
    Publication number: 20170231904
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HCl dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Application
    Filed: January 27, 2017
    Publication date: August 17, 2017
    Inventors: John STRANG, Alexander OKSCHE, Stephen HARRIS, Kevin SMITH, Lucie Helene Jeanne MOTTIER
  • Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
    Publication number: 20150126540
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HCl dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Application
    Filed: January 6, 2015
    Publication date: May 7, 2015
    Inventors: John STRANG, Alexander OKSCHE, Stephen HARRIS, Kevin SMITH, Lucie Helene Jeanne MOTTIER
  • Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
    Publication number: 20150018379
    Abstract: The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ?0.5 mg naloxone HCl dissolved in an application fluid of a volume of ?250 ?l. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
    Type: Application
    Filed: May 11, 2012
    Publication date: January 15, 2015
    Applicant: Euro-Celtique S.A.
    Inventors: John Strang, Alexander Oksche, Stephen Harris, Kevin Smith, Lucie Helene Jeanne Mottier
  • Light fixture
    Patent number: D932090
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: September 28, 2021
    Assignee: Hubbell Incorporated
    Inventors: Gaurav Subodhbhai Amin, Dustin Michael Parsons, David John Strang, Christopher Lane Bailey
  • Light fixture
    Patent number: D981640
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: March 21, 2023
    Assignee: HUBBELL LIGHTING, INC.
    Inventors: Gaurav Subodhbhai Amin, Dustin Michael Parsons, David John Strang, Christopher Lane Bailey